Simon Krige

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
The use of virtual screening to find new drug hits and leads has become commonplace within the pharmaceutical industry. 2D methods have largely been replaced by 3D ligand-based methods and by structure-based methods (docking) where a reliable protein structure is available. However, the computational cost of calculating 3D molecular similarities is much(More)
  • 1